![Arie Belldegrun](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Arie Belldegrun
Fondateur chez
ALLOGENE THERAPEUTICS, INC.
Fortune : 24 M $ au 31/05/2026
Profil
Arie S. Belldegrun est un entrepreneur et un homme d'affaires qui a fondé 6 sociétés, parmi lesquelles : Kite Pharma, Inc., Allogene Therapeutics, Inc. et Agensys, Inc. et qui a été à la tête de 16 sociétés différentes. Actuellement, il occupe le poste de président et associé de Two River Group Holdings LLC, président de Two River Group Management LLC, président de Bellco Capital LLC (qu'il a fondée en 2003), président de Two Rivers Consulting Corp, président d'UroGen Pharma Ltd, président et associé de Two River Consulting LLC, président exécutif d'Allogene Therapeutics, Inc. (qu'il a fondée en 2017), président de Kronos Bio, Inc, coprésident de Breakthrough Properties LLC, directeur général principal de VV Manager LLC (qu'il a fondée en 2017), directeur général principal de Vida Ventures LLC (qu'il a fondée en 2017) (une filiale de VV Manager LLC) et président de Technology Assessment Group. Arie S. Belldegrun est également directeur et professeur à l'Institut d'oncologie urologique de l'UCLA, chef de la division d'oncologie urologique de la David Geffen School of Medicine et directeur général principal chez Vida Ventures LLC (qu'il a fondé en 2017) et siège au conseil d'administration de 5 autres sociétés. Le Dr Belldegrun était auparavant président du conseil d'administration d'Arno Therapeutics, Inc. et président non exécutif chez Arno Therapeutics, Inc. (une filiale d'Arno Therapeutics, Inc.), président du conseil d'administration, président et directeur général d'Equinor ASA, directeur d'Agensys, Inc. (il a fondé la société en 1997), président exécutif, président et PDG de Kite Pharma, Inc. (qu'il a fondée en 2009), président du comité de technologie biologique moléculaire de l'American Urological Association Education & Research, Inc. et chercheur à l'Institut national du cancer, ainsi que membre du Los Angeles Economy & Jobs Committee. Arie S. Belldegrun a obtenu un doctorat de la faculté de médecine Hadassah de l'Université hébraïque et un diplôme d'études supérieures de l'Institut Weizmann des sciences.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2026 | 5 537 887 ( 1,6 % ) | 12 M $ | 31/05/2026 | |
UROGEN PHARMA LTD. 0,84 % | 31/03/2026 | 408 693 ( 0,84 % ) | 11 M $ | 31/05/2026 |
Postes actifs de Arie Belldegrun
| Sociétés | Poste | Début |
|---|---|---|
| UROGEN PHARMA LTD. | Président | 01/10/2012 |
| ALLOGENE THERAPEUTICS, INC. | Fondateur | 01/11/2017 |
Fosun Kite Biotechnology Co., Ltd.
 Fosun Kite Biotechnology Co., Ltd. BiotechnologyHealth Technology Develops immune cell therapies | Directeur/Membre du Conseil | - |
Breakthrough Properties LLC
 Breakthrough Properties LLC Investment ManagersFinance Breakthrough Properties LLC is an active manager. | Président | 01/06/2018 |
VV Manager LLC
 VV Manager LLC Investment ManagersFinance Vida Ventures invests in companies located in the United States. The firm targets companies operating in the life science, healthcare, medicine, and biotechnology sectors. It provides financing for seed, early, and later stage capital requirements. | Fondateur | 01/01/2017 |
ByHeart, Inc.
 ByHeart, Inc. Food: Meat/Fish/DairyConsumer Non-Durables Operates as a baby nutrition company that makes infant formula designed to be close to breast milk | Directeur/Membre du Conseil | 01/10/2019 |
105 W First Street LLC
 105 W First Street LLC Real Estate Investment TrustsFinance Provides real estate investment trusts and financial services | Directeur/Membre du Conseil | - |
Bellco Capital LLC
 Bellco Capital LLC Investment ManagersFinance Bello Capital invests in companies located in the United States. The firm targets companies operating in the life science, real estate, consumer products, and media sectors. It provides financing for later stage capital requirements. | Fondateur | 01/01/2004 |
David Geffen School of Medicine
 David Geffen School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2000 |
| ░░░░░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░ ░░░░░░░░░ ░░░ ░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Anciens postes connus de Arie Belldegrun
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Arie Belldegrun
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
65
Relations au 1er degré
43
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 43 |
|---|---|
Teva Pharmaceutical Industries Ltd.
 Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Email Real Estate.com, Inc.
 Email Real Estate.com, Inc. Financial ConglomeratesFinance Development stage company | Finance |
Equinor ASA
 Equinor ASA Integrated OilEnergy Minerals Engages in production, exploration and marketing of oil & natural gas and generates wind power | Energy Minerals |
Two River Group Holdings LLC
 Two River Group Holdings LLC Investment ManagersFinance Two River Group invests in companies located in the United States. The firm focuses on life sciences and healthcare sectors. It participates in early stage capital requirements. | Finance |
Paramount Acquisition Corp.
 Paramount Acquisition Corp. Financial ConglomeratesFinance Investment vehicle acquiring operating businesses in the healthcare industry | Finance |
Cougar Biotechnology, Inc. /Old/
 Cougar Biotechnology, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer | Health Technology |
Arno Therapeutics, Inc. /Old/
 Arno Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical to treat cancer | Health Technology |
Technology Assessment Group
 Technology Assessment Group Miscellaneous Commercial ServicesCommercial Services Provides research and evaluation services for the effects of drug therapies | Commercial Services |
Agensys, Inc.
 Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Develops medicines for cancers | Commercial Services |
Talon Therapeutics, Inc.
 Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Miscellaneous |
Weizmann Institute of Science
 Weizmann Institute of Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Urological Association Education & Research, Inc.
 American Urological Association Education & Research, Inc. Miscellaneous Commercial ServicesCommercial Services Operates a urologic association | Commercial Services |
Capricor Therapeutics, Inc.
 Capricor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative products for the treatment of cardiovascular diseases | Health Technology |
Los Angeles Economy & Jobs Committee | |
Sonablate Corp.
 Sonablate Corp. Medical SpecialtiesHealth Technology Develops and manufactures high intensity focused ultrasound surgical ablation systems | Health Technology |
Arno Therapeutics, Inc.
 Arno Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on the clinical development of targeted cancer therapies and novel drug candidates for unmet medical needs | Health Technology |
Janssen Oncology, Inc.
 Janssen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer | Health Technology |
Bioscience for the State of California | |
Bellco Capital LLC
Bellco Capital LLC Investment ManagersFinance Bello Capital invests in companies located in the United States. The firm targets companies operating in the life science, real estate, consumer products, and media sectors. It provides financing for later stage capital requirements. | Finance |
Kite Pharma, Inc.
 Kite Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products | Health Technology |
UCLA Institute of Urologic Oncology | |
David Geffen School of Medicine
David Geffen School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UroGen Pharma Ltd.
 UroGen Pharma Ltd. BiotechnologyHealth Technology Develops therapies for urological pathologies | Health Technology |
The Hebrew University Hadassah Medical School
 The Hebrew University Hadassah Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The American Association of Genitourinary Surgeons | |
Ginkgo Bioworks, Inc.
 Ginkgo Bioworks, Inc. Information Technology ServicesTechnology Services Develops biological technology and software solutions | Technology Services |
Cell Design Labs, Inc.
 Cell Design Labs, Inc. BiotechnologyHealth Technology Develops disruptive cell-based therapies for cancer and other devastating diseases | Health Technology |
Fosun Kite Biotechnology Co., Ltd.
Fosun Kite Biotechnology Co., Ltd. BiotechnologyHealth Technology Develops immune cell therapies | Health Technology |
The Parker Institute For Cancer Immunotherapy
 The Parker Institute For Cancer Immunotherapy Miscellaneous Commercial ServicesCommercial Services Operates cancer research | Commercial Services |
Vida Ventures LLC
 Vida Ventures LLC Investment ManagersFinance Acts as Venture Capital Fund | Finance |
VV Manager LLC
VV Manager LLC Investment ManagersFinance Vida Ventures invests in companies located in the United States. The firm targets companies operating in the life science, healthcare, medicine, and biotechnology sectors. It provides financing for seed, early, and later stage capital requirements. | Finance |
Allogene Therapeutics, Inc.
 Allogene Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immuno-oncology | Health Technology |
Kronos Bio, Inc.
 Kronos Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel cancer therapeutics | Health Technology |
ByHeart, Inc.
ByHeart, Inc. Food: Meat/Fish/DairyConsumer Non-Durables Operates as a baby nutrition company that makes infant formula designed to be close to breast milk | Consumer Non-Durables |
105 W First Street LLC
105 W First Street LLC Real Estate Investment TrustsFinance Provides real estate investment trusts and financial services | Finance |
Breakthrough Properties LLC
Breakthrough Properties LLC Investment ManagersFinance Breakthrough Properties LLC is an active manager. | Finance |
Breakthrough Services LLC
 Breakthrough Services LLC Breakthrough Services LLC is an assisted living facility. The company is based in New York. | |
IconOVir Bio, Inc.
 IconOVir Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops oncolytic virus therapy to improve the treatment of patients with cancer | Health Technology |
Soaring Eagle Acquisition Corp.
 Soaring Eagle Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Ginkgo Bioworks Holdings, Inc.
 Ginkgo Bioworks Holdings, Inc. Medical/Nursing ServicesHealth Services Develops biological engineering products and custom microbes | Health Services |
D3C1 Allston Co-Investment LP
 D3C1 Allston Co-Investment LP Financial ConglomeratesFinance Functions as investment fund | Finance |
76bio, Inc.
 76bio, Inc. Pharmaceuticals: MajorHealth Technology Develops transformational therapies for patients with life-threatening disease | Health Technology |
